These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 16809614
21. [Disease transformation in imatinib mesylate treated Philadelphia chromosome-positive chronic myelogenous leukemia patients achieved cytogenetic remissions]. Jiang Q, Chen SS, Jiang B, Jiang H, Lu Y, Lu DP. Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec 18; 37(6):612-5. PubMed ID: 16378113 [Abstract] [Full Text] [Related]
22. Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells. Larsson N, Billström R, Lilljebjörn H, Lassen C, Richter J, Ekblom M, Fioretos T. Cancer Genet Cytogenet; 2010 Jun 18; 199(2):89-95. PubMed ID: 20471511 [Abstract] [Full Text] [Related]
23. High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia. Kantarjian H, Talpaz M, O'Brien S, Garcia-Manero G, Verstovsek S, Giles F, Rios MB, Shan J, Letvak L, Thomas D, Faderl S, Ferrajoli A, Cortes J. Blood; 2004 Apr 15; 103(8):2873-8. PubMed ID: 15070658 [Abstract] [Full Text] [Related]
31. Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib. Loriaux M, Deininger M. Leuk Lymphoma; 2004 Nov 15; 45(11):2197-203. PubMed ID: 15512807 [Abstract] [Full Text] [Related]
37. Development and progression of a Philadelphia-chromosome-negative acute myelocytic leukemia clone in a patient with Philadelphia-chromosome-positive chronic myelocytic leukemia. Cullen MJ, Richards SJ, Dickinson H, Carter C, Swirsky DM, Owen RG. Cancer Genet Cytogenet; 2004 Jan 15; 148(2):170-3. PubMed ID: 14734234 [Abstract] [Full Text] [Related]
39. Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors. de Mello Conchon MR, Bendit I, Ferreira P, Lima W, Kumeda C, Dias L, de Alencar Fischer Chamone D, Dorlhiac-Llacer PE. Int J Hematol; 2009 Jan 15; 89(1):123-125. PubMed ID: 19093165 [No Abstract] [Full Text] [Related]